Mutations in p53 protein, especially in the DNA binding domain is one of the major hallmarks of cancer. The R273 position is a DNA contact position and has several oncogenic variants. Surprisingly, cancer patients carrying different mutant-variants of R273 in p53 have different survival rates indicating that the DNA contact inhibition may not be the sole reason for reduced survival with R273 variants.
Introduction.
Abnormal protein behavior is the key cause to several clinical conditions. The anomaly in the protein behavior can be due to mutations, misfolding of the protein, or non-clearance of the protein by degradation pathways leading to accumulation and aggregation. Protein aggregation is linked to several neurodegenerative diseases like amyloid beta aggregation in Alzheimer's disease , aggregates of αsynuclein in Parkinson's disease (1) (2) (3) (4) (5) (6) . Over the last few decades, a good amount of work suggests that the misfolding and aggregation of the p53 protein is a pathological condition in cancer (7) (8) (9) . The p53 protein, central to the human physiology, involved in maintaining genomic stability by inducing cellcycle arrest, senescence and apoptosis (10) (11) (12) (13) , is found to be frequently mutated in cancer and majority of the mutations are present in the DNA binding domain of p53 (14) (15) (16) . Selective mutations in this central DNA binding domain are more frequent in tumor and are thought to be an important factor for their uncontrolled growth (17, 18) . It is also reported that a few of these mutations alter the structure of the protein that lead to its misfolding and aggregation (19) (20) (21) . R273 and R248 are two such hotspot DNA contact mutations which show maximum frequency of alteration in cancer (22, 23) . R273 is one of previously defined DNA-contact position, the mutation of which is shown to have the most severe impact on cancer patients. The R273 position has the highest frequency of mutation in the cancers of the brain, ovary, pancreas, and liver (24) (25) (26) (Figure 1 , S1a, Table S1 ). The R273 residue is mutated to different amino acids in different types of cancer. The three most common variants of R273 (27) . This suggests that the different mutant-variants formed due to alterations in the same codon have different gain-of-function. In order to explore the different function of R273 variants in cancer, we have performed an analysis of The Cancer Genome Atlas. We analyzed survival probability from TCGA data (28, 29) of breast cancer patients with mutations in R273 position and WTp53 (30) (31) (32) . The test estimates the Hazard Ratio (HR) using the Log-rank (Mantel-Cox) Test (33) , which is the ratio between the risk of the outcome in the group possessing mutations in p53 and the group with WTp53. The HR value < 1 indicates that the WT-group has better survival than the mutant-group. As expected, we measured better survival for patients with WTp53 in breast cancer ( Figure S1b there is no clear understanding of the effect of R273 mutations on structure of p53. For another similar type of DNA-contact amino acid R248, reports suggest that the R248Q mutant destabilize the structure and promote the aggregation of p53 (21, (34) (35) (36) (37) (38) (39) (40) . However, a meticulous correlation if these structural changes are linked to differential oncogenicity is missing in the literature. Our in silico studies also suggested that these variants have a different propensity for aggregation and self-assembly. We used the aggregation prediction softwares AGGRESCAN (41) and PASTA (42) to check the aggregation propensities of mutant-variants of R273 compared to the WTp53 ( Figure S2 ). A hepta-peptide FEVXVCA has been used for the analysis, where 'X' is the variant amino acid. The AGGRESCAN analysis shows that the leucine variant has the maximum aggregation propensity followed by the cysteine variant. The wildtype and the histidine variant show little aggregation tendency. The PASTA analysis shows that the cysteine variant has the maximum tendency to form cross-β amyloid structures, followed by leucine, histidine and the wildtype hepta-peptides respectively. Therefore, our in silico prediction studies reveal that the [R273C] variant peptide is highly amyloidogenic whereas [R273L] peptide shows maximum aggregation. We next performed a spectrum of biochemical, biophysical and imaging studies to probe the difference between the self-assembly of the three p53 variants [R273L]p53, [R273H]p53 and [R273C]p53. Our studies clearly indicate stark difference between their assembly properties that might play a role in the different survival rates in different cancers. These observations reinforce the fact that personalized process specific therapeutics and medication might be a parallel pathway for cancer treatment.
Materials & methods
Chemicals. All reagents are of molecular biology grade. Ultrapure water is used for all experiments Propensity of aggregation of R273 hotspot variants using prediction algorithms. AGGRESCAN and PASTA2.0 algorithms are used to understand the aggregation characteristics of R273variants in heptapeptide of p53 FEVRVCA. Aggrescan(41) is a server to predict and evaluate aggregation hotspots in polypeptide. The hotspot area of aggregation per residue is calculated. PASTA 2.0(42) (prediction of amyloid structure aggregation) predicts aggregation prone region by evaluating the stability of putative cross-beta pairings within different stretch of sequences.
Molecular cloning and mutagenesis. The N-terminal truncated p53 (residues 82−393) construct was generously shared by C. Arrowsmith (43) Addgene (plasmid 24867). All the p53[R273] point mutations are done using overlap extension polymerase chain reaction by primers which are shown in Table S2 and then digested with Nde1(NEB) & BamH1(NEB) and ligated in the pET15b vector. The constructs are confirmed by sequencing. ANS fluorescence study. ANS binding studies are performed in Edinburg spectro-fluorometer with temperature maintained at 37°C using peltier. ANS fluorescence intensity is observed at 492nm with excitation at 375 nm with excitation and emission bandwidths set at 2 nm and 3 nm respectively. ANS emission is recorded after every 5second for 1hour at 37°C. The concentration of ANS dye is maintained at 100µM with WTp53 and its variants at concentration of 5µM.
Expression and purification of p53
Ellman's assay. WTp53 and its R273 variants fresh and aged (incubated at 37°C for 30min) are incubated with Ellman's reagent at a molar ratio of 1:5 (1µM of protein with 5µM of Ellman's reagent) for 5min and then take absorbance in UV-visible spectrometer from 200nm to 600nm.
Cytotoxicity using MTT assay. Relative cell viability is determined using MTT (sigma-Aldrich) assay. 
Molecular Dynamics Simulations.
All the molecular dynamics (MD) simulations were setup using the QwikMD(44) plugin of VMD(45) and run using NAMD(46) version 2.12. Short initial peptide structure are obtained from WTp53 (PDB ID: 1TUP). Then the peptide structure is energy minimized first in vacuum and then in solvated state. All the mutation has been performed in-silico using QwikMD only.
The mutated structure is also energy minimized using the same protocol. The energy minimized structure is then subjected for 20 ns long MD simulation. Then MD trajectory is analyzed using grcarma. The most populated conformation obtained from MD simulation is used as the initial structure for the aggregation simulation. Then 25 peptides are arranged in random orientation but equidistant form each other having distance of 40Å from its neighboring peptide in a square shaped fashion. After the addition of hydrogen atoms, the structures are aligned with the longest axis along the Z-axis and solvated with TIP3P(47) water to form a box with a distance of 15Å between the edge of the box and the protein in all the axis. The Na + and Clions corresponding to a concentration of 150 mM are then placed randomly in the water box by replacing the water molecules. The system is then minimized for 5000 steps with the position of the protein atoms fixed followed by 5000 steps without any restraints. The temperature of the system is then gradually raised to 300K at a rate of 1 K every 600 steps with the backbone atoms restrained. Thisis followed by equilibration for 5 ns with the backbone atoms restrained followed by 10 ns of the production run with no restraints. For all the steps, the pressure is maintained at 1 atm using Nose-Hoover method (48) , thelong-range interactions were treated using the particle-mesh Ewald (PME)(49) method and the equations of motion are integrated using the r-RESPA scheme to update short-range van der Waals interactions every step and long-range electrostatic interactions every 2 steps. [R273L]p53 shows some initial destabilization as observed by the broadening of the fluorescence spectrum compared to the WTp53 at 4°C. However, the circular dichroism spectra are similar in all variants suggesting no significant alteration in the secondary structure ( Figure 1b ).
Results

Expression and Purification of WT and R273 variants of p53.Four
Investigating the DNA-binding of R273 variants of p53.
The R273 is one of the DNA-contact positions in p53 that allows specific binding between p53 and DNA. The mutation of this amino acid to any other amino acid leads to altered DNA binding. To test this hypothesis, we have employed an electrophoretic mobility shift assay (EMSA). EMSA is an effective way to screen for the DNA-binding characteristic of proteins (50) (51) (52) . We have selected the Gadd 45-30mer dsDNA (Table S2) variants are incubated at a ratio of 8:1 with dsDNA (8µg of protein with 1µg of dsDNA) at 4°C for 30min then shift to 22°C for 40 min followed by agarose gel electrophoresis in 1X TB buffer. At pH 8.5, we observe retardation in the mobility of DNA incubated with WTp53 in contrast to when incubated with the R273 mutant-variants. This indicates that only WTp53 binds to DNA and the mutants cannot ( Figure 1d ). Also we observe, free DNA in the lanes with of R273 mutant-variants whereas p53-DNA complex in the lane withWTp53. Following the establishment of the loss of function due to mutation, we next aimed to study if there are structural implications as well due to these mutations in addition to the functional.
Stability studies of p53 R273 mutant-variants in vitro.
It has been reported earlier that the native folded structure of p53 shows predominantly tyrosine fluorescence whereas tryptophan fluorescence prevails in case of denatured p53 (56) . Post purification ( We next assessed the thermal stability of the variants using thermal shift assay (TSA) probed by syproorange fluorescence (Figure 1f , Figure S4 ). TSA of the fresh WTp53 shows only one transition around 40 o C.
[R273H]p53 also shows a single transition in the same region. However, the variants (Table S3 , Figure S4 , and S5). We see that the T m of the variants is lower than that of the wild type form. These studies indicate that the mutation at the R273 position destabilizes the structure of the protein leading to altered structure and folding. In the next set of studies, we focused on understanding if the loss in the stability of the variants lead to misfolding and aggregation as observed for some other p53 variants in the literature.
Amyloidogenic behavior of R273 variants of p53.
We studied the aggregation characteristics of the R273 variants using Thioflavin T (ThT) as reported in the literature (7, 20, 38, 40, 57, 58) . All the vari- (Figure 2d1-d4) . The wild type protein shows globular assembly, while all the oncogenic variants show fibrillar assemblies typical to those of amyloid fibres.
Although [R273H]p53 shows sparsely populated fibrillar aggregates. This is exactly in accordance to what we have observed in our experiments involving ThT and Congo red binding.
Understanding the molecular mechanism for the unique stability and self-assembly of different R273
variants of p53. Next, we attempted to understand the mechanism of aggregation in the different variants that leads to the altered self-assembly. We used the ANS fluorescence studies to check how the different variants of the protein unfold during the aggregation process. ANS is a dye that binds to the solvent exposed hydrophobic patches of protein.
In our experiments, we see that except for the wild type Interestingly, the inter-residue contact-maps from the peptides feature different patterns of interaction for different variants of the peptide-stretch indicating that the initial nuclei formation is not same. Similar inferences are also made from the ThT kinetics, ANS binding and the studies using the Elman's reagent. Further, we observed that the development of the secondary structures during the simulation is different for the different variants ( Figure 4) . The peptide-stretch resembling WTp53 mostly remain as random-coil. In fact, only two out of twenty-five peptides showed random coil to helix, and five peptides showed random coil to transient -strand transformation (Figure 4a ). In contrast, appearance of the secondary structures is frequently observed in all the variant peptides (Figure 4b,c,d ). All the variants undergo secondary structural transition to -strand very frequently.
[R273L]p53 shows the greatest extent of -strand transformation (Figure 4d ). Notably, [R273C] also undergo transition to α-helical structure and to pi-helix in a greater extent which may be one of the key to its different aggregation propensity. As for tau protein involved in Alzheimer's disease, α-helix is considered to initiate the aggregation process (61) .These structural transformations could be the key to stabilize as well as increase the size of the aggregates for mutant-variants, as clusters with parallel and anti-parallel -strand organization are also noticed in the simulations.The difference in the contact map, H-bonds and dissimilar secondary structure formation in the course of the simulation suggest that the proteins misfold via different aggregation pathways, which in turn can result in different levels of pathogenic aggression as observed in the TCGA analyses.
Cytotoxicity mediated by the [R273X]p53 oligomers.
It is a well-documented fact that amyloidogenic oligomers of several proteins including p53 are toxic and lead to reduced cell viability (62, 63) . We Figure 5b) . We have already observed in the TCGA analysis for the cancer patients that the R273 variants decrease the survival of the patients (Figure 5b ). This decrease in the survival may be because of the enhanced viability conferred to the cancer cells by the mutant-variants as seen in these experiments.
Discussion
Mutations in physiological proteins lead to several pathogenic conditions and p53 is one such classic example. Being central to several physiological processes, a slight anomaly in its genetic makeup leads to clinical conditions. In this study, we selected the R273 position in p53 to study the effect of the pathological R273 mutant-variants on the structure and function of the protein. The R273 position is a DNA contact position and interestingly mutated to different amino acids leading to different forms of cancer. The range of mutations causes different extent of pathogenic aggression. Our studies show that each of the variant proteins are unique in their ways when it comes to the structure-function relationship. All the variants, unlike the WT, show compensated DNA binding. This result is apparent as the position R273 is a DNA contact amino acid and hence, changing it to any other residue will lead to loss of the function. However, as we argued earlier, if lack of DNA binding is the only reason for cancer pathogenesis, then why the different variants will lead to different extent of clinical symptoms and side effects. This can happen only if there are associated structural and functional roles of these oncogenic variants in physiology.
All the three mutant-variants studied show altered stability compared to the WTp53. [R273C]p53 most prevalent in the cancer of the brain where the condition is oxidizing (66, 67) . Also, the role of disulphide bonds in the self-assembly and amyloidogenicity of neurodegenerative diseases is well documented in the literature (68) . Hence, our studies indicate that understanding the link between disulphide mediated amyloid aggregate formations and brain cancer will be an interesting area to explore in future.
Conclusion.
Our studies on the different R273 variants of p53 clearly indicate the role of individual amino acids in the stability and self-assembly of the protein. It is interesting to note that changing a single amino acid leads to different structure-function relationship in the protein. These studies also emphasize that it is not only the lack in DNA contact that leads to p53 inactivation in certain cancers, but also the structural changes that are associated with the mutations. These observations, thus, call for the need of developing therapeutic strategies that will consider the hallmark of each of these mutations as a therapeutic target rather than considering the mutation as the target. We do understand that there may be other simultaneous mutations in the p53 gene that also affect the pathogenesis of the disease, however, our studies indi- Various color like grey, green, blue, pink, and yellow represent random coil, turn, π-helices, α-helices, and β-strand, respectively. 
